Responses
Clinical/translational cancer immunotherapy
Original research
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.
